Abstract
Neurodevelopmental disorders (NDD) encompass intellectual disabilities and behavioral dysregulation that begin during development. Improved quality of care has resulted in increasing lifespan of these individuals and many of them are seen in adult clinics. There is growing recognition of cardiovascular morbidity and mortality in this population. However, physicians and endocrinologists are not familiar with the prevalence of obesity and cardiometabolic risk in this population. Management of individuals with NDD requires a good understanding of the factors that lead to obesity and cardiometabolic risk and the ability to address the unique challenges in these individuals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
